Meds Apotek AB (publ) (OSTO:MEDS) ROCE %: 16.71% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:MEDS Meds Apotek AB (publ) OSTO:MEDS
11 GF Score
Price kr21.30
! 2 Warning Signs
View Full Analysis

What is Meds Apotek AB (publ) ROCE %?

Meds Apotek AB (publ) OSTO:MEDS +3.90% 11 ROCE % is 16.71% as of Jun. 2026. GuruFocus rates OSTO:MEDS with a GF Score™ of 11/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Meds Apotek AB (publ)'s annualized ROCE % for the quarter that ended in Jun. 2026 was 16.71%.

Meds Apotek AB (publ)  (OSTO:MEDS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Meds Apotek AB (publ) ROCE % Related Terms

Meds Apotek AB (publ) ROCE % Historical Data

* Premium members only.

The historical data trend for Meds Apotek AB (publ)'s ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meds Apotek AB (publ) ROCE % Chart

Meds Apotek AB (publ) Annual Data
Trend Dec21 Dec23 Dec24 Dec25
ROCE %
0.00 -38.93 -7.38 -1.92

Meds Apotek AB (publ) Quarterly Data
Dec21 Jun22 Dec23 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 -18.71 -0.98 16.07 16.71
OSTO:MEDS
11GF Score
Meds Apotek AB (publ) OSTO:MEDS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Meds Apotek AB (publ) ROCE % Calculation

Meds Apotek AB (publ)'s annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-1.978/( ( (208.164 - 132.202) + (270.703 - 140.655) )/ 2 )
=-1.978/( (75.962+130.048)/ 2 )
=-1.978/103.005
=-1.92 %

Meds Apotek AB (publ)'s ROCE % of for the quarter that ended in Jun. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=23.092/( ( (287.063 - 151.839) + (274.506 - 133.334) )/ 2 )
=23.092/( ( 135.224 + 141.172 )/ 2 )
=23.092/138.198
=16.71 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 16.71% mean?
Meds Apotek AB (publ) (OSTO:MEDS) has a ROCE % of 16.71% as of Jun. 2026.
Is Meds Apotek AB (publ)'s ROCE % too high?
Meds Apotek AB (publ)'s current ROCE % is 16.71%. The Retail - Cyclical industry median ROCE % is 7.66. Meds Apotek AB (publ)'s value of 16.71% is 118.1% above this industry median. Overall, Meds Apotek AB (publ) has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Meds Apotek AB (publ)'s ROCE % compare to AMZN and BABA?
Meds Apotek AB (publ)'s ROCE % of 16.71% can be compared against companies in the Retail - Cyclical industry. The industry median ROCE % is 7.66. Meds Apotek AB (publ)'s value of 16.71% is 118.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Retail - Cyclical company?
The median ROCE % among Retail - Cyclical companies is 7.66, based on 1,117 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Meds Apotek AB (publ)'s current ROCE % of 16.71% is 118.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Retail - Cyclical industry, the median ROCE % is 7.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Meds Apotek AB (publ)'s current ROCE % is 16.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meds Apotek AB (publ) stock overvalued right now?
Meds Apotek AB (publ) (OSTO:MEDS) has a current ROCE % of 16.71%. The current ROCE % is 16.71% and 118.1% above the Retail - Cyclical industry median of 7.66. Meds Apotek AB (publ)'s overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Meds Apotek AB (publ) (OSTO:MEDS), the current ROCE % is 16.71% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Meds Apotek AB (publ) Business Description

Address Elektravagen 26, Port 136, Hagersten, Stockholm, SWE, 12630
Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Medical Products Agency, the Swedish Food Agency and the E-Health Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty products, children's products, fitness products, food and drink and home & household products.
11GF Score

Get the complete analysis for OSTO:MEDS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr21.30
Price